Literature DB >> 3732529

Constituents of cigarette smoke inhibit human granulosa cell aromatase.

R L Barbieri, P M McShane, K J Ryan.   

Abstract

Recent epidemiologic studies suggest that women smokers have lower endogenous estrogen levels than nonsmokers. The effects of aqueous extracts of cigarette smoke on aromatase were evaluated in cultures of human granulosa cells. Aqueous extracts of cigarette smoke inhibited the conversion of androstenedione (delta 4A) to estradiol in a dose-dependent manner. Dialysis experiments demonstrated that 90% of the inhibitory activity of aqueous extracts of cigarette smoke was in the less than 1000 mol wt fraction. Removal of the aqueous extract of cigarette smoke from the culture medium resulted in a complete reversal of the inhibition of delta 4A aromatization. Addition of supraphysiologic concentrations of delta 4A (73 microM) to the culture medium blocked the smoke-induced inhibition of aromatization. Two low-molecular-weight components of cigarette smoke, nicotine and anabasine, inhibited granulosa cell aromatase in a dose-dependent manner. These studies suggest that constituents of cigarette smoke inhibit a major steroidogenic pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732529

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  20 in total

1.  Cigarette smoking, steroid hormones, and bone mineral density in young women.

Authors:  M Daniel; A D Martin; D T Drinkwater
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Cindy Ta Pau; Candace C Keefe; Corrine K Welt
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

3.  Increased long-term recreational physical activity is associated with older age at natural menopause among heavy smokers: the California Teachers Study.

Authors:  Aina Emaus; Christina Dieli-Conwright; Xinxin Xu; James V Lacey; Sue A Ingles; Peggy Reynolds; Leslie Bernstein; Katherine D Henderson
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

4.  A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up.

Authors:  Youjin Je; Susan E Hankinson; Shelley S Tworoger; Immaculata De Vivo; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-22       Impact factor: 4.254

5.  Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.

Authors:  MaryFran R Sowers; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Sioban D Harlow; John F Randolph
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.

Authors:  Ashley S Felix; Hannah P Yang; Gretchen L Gierach; Yikyung Park; Louise A Brinton
Journal:  Cancer Causes Control       Date:  2014-02-01       Impact factor: 2.506

7.  Life course exposure to smoke and early menopause and menopausal transition.

Authors:  Hebatullah Tawfik; Jennie Kline; Judith Jacobson; Parisa Tehranifar; Angeline Protacio; Julie D Flom; Piera Cirillo; Barbara A Cohn; Mary Beth Terry
Journal:  Menopause       Date:  2015-10       Impact factor: 2.953

Review 8.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

Review 9.  Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Authors:  William I Fisher; Aimee K Johnson; Gary R Elkins; Julie L Otte; Debra S Burns; Menggang Yu; Janet S Carpenter
Journal:  CA Cancer J Clin       Date:  2013-01-25       Impact factor: 508.702

10.  Influence of smoking on outcome of COH and IUI in subfertile couples.

Authors:  Jacob Farhi; Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2009-09-15       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.